Oncopeptides Announces Two Poster Presentations at the International Myeloma Workshop
Stockholm – September 14, 2019 - Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that our two poster presentations have been made public at the 17th International Myeloma Workshop (IMW) meeting in Boston, Massachusetts, USA.The posters presented at IMWThe first poster presentation was held during Poster Session I, Multiple Myeloma Genomics – under the title: Aminopeptidase gene expression in myeloma. The second poster presentation was held during Poster Session II, Treatment of Previously Treated Myeloma –under the title: Quality of life treatment for relapsed/refractory